Home
Categories
Ingredients
Research & Development
Manufacturing
Packaging
Active Nutrition
Cardiovascular
Digestion
Cognitive
Finance
Regulatory
Company News
Events
Directory
Search
Close search
Home
Company
XPhyto Therapeutics
XPhyto Therapeutics
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Arla Foods Ingredients new beverage concept for nutrition-conscious gamers
The energy drink contains 15g of protein, taurine, magnesium, zinc, caffeine and vitamins A, B3, B6 and B12
The role of traceability in the nutraceutical supply chain
The exponential growth of the nutraceutical sector, combined with the unprecedented growth in online marketplaces, makes nutraceuticals highly vulnerable to vast counterfeiting...
The power of the pomegranate in bolstering gut health
Supplementation with Punica granatum extract can help to enhance gut health in three ways, a novel study finds
Degradation of vitamins, probiotics and other active ingredients caused by exposure to heat, water and sunlight
Vitamins and probiotics (and other active ingredients) can be substantially affected by exposure to heat, water and/or sunlight
Lubrizol to showcase microencapsulation technology at Vitafoods Europe 2024
The company will showcase technologies that assist in iron delivery for incorporation into supplement formulations
Upcoming event
Vitafoods Europe
14–16 May 2024 | Exhibition | Palexpo, Geneva
See all
Related Content
Research & Development
XPhyto begins R&D operation for CBD-infused beverages
German subsidiary Bunker is working with the International Beverage Research Center Weihenstephan
Manufacturing
Cannabis extraction and processing lab to enter operation in Canada
XPhyto Therapeutics will operate the site located at the University of Alberta
Ingredients
XPhyto Therapeutics inks distribution deal with cannabis grower
The supplier is an international grower and extractor with ongoing EU GMP certification for high THC flower and outdoor high and low THC cannabis strains
Design & Build
Canadian cannabis firm overhauls EU hydroponics and extraction site
XPhyto Therapeutics has engaged Stephen Schroeder with the design, renovation, and commissioning of plant in Bavaria with licence to extract up to 70 strains
Subscribe now